Enveric Biosciences ENVB
NASDAQ ENVB
$1.46 -0.02 (-1.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Depreciation & Amortization (CF) (2014 - 2026)

Updated

Enveric Biosciences (ENVB) posted Depreciation & Amortization (CF) of $36,826 for Q2 2026, down 7.9% from $39,980 a year earlier and down 1.1% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Enveric Biosciences was $153,918, down 4.8% year-over-year; for FY2025, it came in at $158,676, down 6.0% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a four-year compound annual growth rate of 85.8% (FY2021 to FY2025).
  • In prior years, Enveric Biosciences' Depreciation & Amortization (CF) was $168,739 in FY2024 (-3.7%), $175,228 in FY2023 (+10.1%), $159,160 in FY2022 and $13,310 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q1 2022.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last 12 quarters, with an average decline of 5.5% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2022, with growth of 300.3%; the weakest was Q3 2022, with a decline of 74.4%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $37,240 (Q1 2026), $39,483 (Q4 2025) and $40,369 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Enveric Biosciences 5.86 Mn -15.78 Mn - 36,826.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36,826.00
Mar 31, 2026 37,240.00
Dec 31, 2025 39,483.00
Sep 30, 2025 40,369.00
Jun 30, 2025 39,980.00
Mar 31, 2025 38,842.00
Dec 31, 2024 40,301.00
Sep 30, 2024 42,626.00
Jun 30, 2024 42,591.00
Mar 31, 2024 43,221.00
Dec 31, 2023 42,494.00
Sep 30, 2023 44,105.00
Jun 30, 2023 44,331.00
Mar 31, 2023 44,298.00
Dec 31, 2022 44,310.00
Sep 30, 2022 44,458.00
Jun 30, 2022 43,315.00
Mar 31, 2022 27,077.00
Dec 31, 2021 11,070.00
Sep 30, 2021 173,696.00
API Access

Enveric Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ENVB&period=max&api_key=YOUR_API_KEY